Navigation Links
Calling for a Cure
Date:2/29/2008

Leading Asbestos-Cancer Group: CNN Expose Highlights Urgent Need for

Medical Research

SANTA BARBARA, Calif., Feb. 29 /PRNewswire/ -- CNN's recent expose on asbestos in children's toys demonstrates the shocking reality that the deadly carcinogen is virtually everywhere in our environment.

For decades, asbestos was used heavily in Navy ships and shipyards; in workplaces; in common building materials including drywalls, flooring, roofing materials, and cement pipes; in automotive products like brake pads; and even in common consumer products like hair dryers. As a result, the carcinogen has permeated our homes, offices and schools. The EPA estimates that one asbestos product alone -- a highly toxic "vermiculite" insulation -- is present today in 35 million U.S. homes.

Tens of millions of Americans have already been exposed to asbestos, whether they knew it or not. Ten thousand Americans are now dying each year from past exposures that are too late to prevent. Deadly exposures will continue long into the future, because of all the asbestos already in our environment and the impossibility of remediating it. The tragedy of 9/11 demonstrates the continued, long-term threat. Estimates of the amount of asbestos released around Manhattan range as high as 1,000 tons. The impact pulverized the asbestos material into microscopic, easily respirable fibers to which the firefighters, rescue workers and other heroes were exposed. In the ensuing months, workers, residents and school children in the area continued to be exposed.

For all those who are now sick, who have already been exposed and are at risk, or who will inevitably be exposed in the future, the only hope is research now to develop effective medical treatments. But research on the asbestos-cancer, mesothelioma, lags far behind other cancers. As a result of the limited treatment options, most mesothelioma patients die within one year of diagnosis.

The Mesothelioma Applied Research Foundation (Meso Foundation) therefore is dedicated to promoting the research critically-needed to develop treatments for mesothelioma. As the nation's only independent, scientifically-based source of private mesothelioma research funding, The Meso Foundation has awarded over $5 million in research grants to stellar projects around the world.

Additionally, through The Meso Foundation's advocacy, research funding for asbestos-related diseases has been included in the "Bruce Vento Ban Asbestos and Prevent Mesothelioma Act" which is currently in the hands of Congress. A strong effort on the federal level is needed now to develop treatments for asbestos-cancer. Says, Meso Foundation Executive Director Chris Hahn, "We have accomplished a lot with limited, private funding. It is time for the federal government to partner with us in the search for a cure before more lives are lost."


'/>"/>
SOURCE The Meso Foundation
Copyright©2008 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with ... today announced participation at the following conferences: ... Maidstone Life Sciences conference "Cancer Immunotherapy Conference" at the ... York, NY . Agenus will participate in three ... Robert B. Stein , M.D., Ph.D., President, R&D ...
(Date:3/23/2017)... 23, 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW ... therapies for solid tumor cancers, today announced that ... it announced last Friday, March 17, 2017. ... investors securities totaling 28,843,692 shares, comprised of 18,843,692 ... shares of Class C Warrants pre-funded at the ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... recently selected by the Connecticut Technology Council (CTC) as a 2017 Women of ... thirteenth annual Women of Innovation Awards Dinner. , The dinner recognizes women accomplished ...
(Date:3/23/2017)... , March 23, 2017  Agriculture technology company ... A financing and note conversion to commercialize its Cool ... is focused on developing products that are simultaneously profitable ... million in the last 18 months. This latest round ... Bridge Venture Partners. The company,s primary ...
Breaking Biology Technology:
(Date:3/2/2017)... 2017 Australian stem cell and regenerative medicine ... signed an agreement with the Monash Lung Biology Network, ... Institute and Department of Pharmacology at Monash University, ... study to support the use of Cymerus™ mesenchymal stem ... Asthma is a chronic, long term lung condition ...
(Date:2/28/2017)... Spanien, 27. Februar 2017  EyeLock LLC, ein marktführendes ... seine erstklassige biometrische Lösung zur Iris-Erkennung auf ... X16 LTE auf dem Mobile World Congress ... Qualcomm-Stand in Halle 3, Stand 3E10, vorstellen. ... Sicherheitsplattform Qualcomm Haven™ – eine Kombination aus ...
(Date:2/22/2017)... -- With the biometrics market to exceed $10 ... that innovative and agile startups must incorporate into ... changing competitive landscape: multifactor authentication (MFA), point-of-sale (PoS), ... "Companies can no longer afford to cut corners ... Pavlakis , Industry Analyst at ABI Research. "Pairing ...
Breaking Biology News(10 mins):